A 32 year old woman with intermittent wheeze and cough uses salbutamol pressurised metered dose inhaler (pMDI) about three times per week. She has no nocturnal symptoms and normal spirometry between episodes. According to Australian asthma guidelines, how should her reliever medication be delivered to optimise lung deposition and minimise systemic side effects?